Clinical outcomes and characteristics of patients with
AML
Acute myeloid leukemia
MDS
TP53
myelodysplastic syndrome
stem cell transplant
Journal
Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
5
5
2020
medline:
28
4
2021
entrez:
5
5
2020
Statut:
ppublish
Résumé
Mutations in the tumor suppressor gene
Identifiants
pubmed: 32362171
doi: 10.1080/10428194.2020.1759051
pmc: PMC7603787
mid: NIHMS1637316
doi:
Substances chimiques
TP53 protein, human
0
Tumor Suppressor Protein p53
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2180-2190Subventions
Organisme : NCI NIH HHS
ID : P30 CA016359
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Références
Blood. 2017 Aug 10;130(6):699-712
pubmed: 28607134
Am J Hematol. 2019 Jun;94(6):650-657
pubmed: 30900772
Lancet Oncol. 2018 Dec;19(12):1668-1679
pubmed: 30442503
J Hematol Oncol. 2017 Jan 18;10(1):20
pubmed: 28100265
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Blood. 2014 May 8;123(19):2960-7
pubmed: 24652988
Nat Genet. 2018 Oct;50(10):1381-1387
pubmed: 30224644
Leukemia. 2016 Mar;30(3):666-73
pubmed: 26514544
Oncotarget. 2016 Jun 14;7(24):36266-36279
pubmed: 27167113
Blood Rev. 2017 May;31(3):119-128
pubmed: 27923516
Best Pract Res Clin Haematol. 2018 Dec;31(4):379-383
pubmed: 30466751
Haematologica. 2019 Mar;104(3):516-523
pubmed: 30309854
J Clin Oncol. 2014 Sep 1;32(25):2691-8
pubmed: 25092778
N Engl J Med. 2017 Feb 9;376(6):536-547
pubmed: 28177873
N Engl J Med. 2016 Nov 24;375(21):2023-2036
pubmed: 27959731
Blood Rev. 2020 Sep;43:100650
pubmed: 31883804
Lancet Haematol. 2019 Jan;6(1):e29-e37
pubmed: 30545576
Leukemia. 2008 Feb;22(2):240-8
pubmed: 18200041
Leukemia. 2019 Jul;33(7):1620-1634
pubmed: 30737482
Blood. 2018 Oct 18;132(16):1703-1713
pubmed: 30190321
Nature. 2015 Feb 26;518(7540):552-555
pubmed: 25487151
Cancer. 2016 Nov 15;122(22):3484-3491
pubmed: 27463065
Blood Adv. 2018 Dec 26;2(24):3608-3617
pubmed: 30567725
J Clin Oncol. 2017 Mar 20;35(9):934-946
pubmed: 28297624
Cell. 2009 May 1;137(3):413-31
pubmed: 19410540
Clin Lymphoma Myeloma Leuk. 2017 Nov;17(11):753-758
pubmed: 28687222
Blood. 2017 Apr 27;129(17):2347-2358
pubmed: 28223278
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Leukemia. 2017 Mar;31(3):705-711
pubmed: 27680515
J Clin Oncol. 2003 Dec 15;21(24):4642-9
pubmed: 14673054
Nat Rev Cancer. 2018 Feb;18(2):89-102
pubmed: 29242642
Blood. 2018 Jun 28;131(26):2989-2992
pubmed: 29769261
Blood. 2016 Aug 4;128(5):686-98
pubmed: 27288520
Leukemia. 2017 Jun;31(6):1391-1397
pubmed: 28111463
Science. 2019 Aug 9;365(6453):599-604
pubmed: 31395785
Nature. 2016 Mar 24;531(7595):471-475
pubmed: 26982726
Haematologica. 2017 Dec;102(12):2030-2038
pubmed: 28971906
Blood Rev. 2019 Sep;37:100587
pubmed: 31400824
Blood. 2006 Jul 15;108(2):419-25
pubmed: 16609072
Leukemia. 2019 Jul;33(7):1747-1758
pubmed: 30635634
Leuk Res. 2015 Mar;39(3):348-54
pubmed: 25573287
Blood. 2012 Mar 1;119(9):2114-21
pubmed: 22186996
Blood. 2013 Nov 21;122(22):3616-27; quiz 3699
pubmed: 24030381
Nat Rev Clin Oncol. 2018 Jan;15(1):13-30
pubmed: 28948977
Nat Med. 2020 Oct;26(10):1549-1556
pubmed: 32747829
J Clin Oncol. 2012 Oct 10;30(29):3633-9
pubmed: 22965953
N Engl J Med. 2018 Sep 13;379(11):1028-1041
pubmed: 30207916